Mirati Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 22, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial-stage targeted oncology company, today announced that the Company will present at the 41st J.P. Morgan Annual Healthcare Conference, on January 9, 2023. David Meek, chief executive officer,…

Click here to view original post